Compare 10X Genomics Inc (TXG) vs Veritone Inc (VERI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Veritone Inc — how do they compare? 10X Genomics Inc trades at $58.6 (market cap $7.61B), while Veritone Inc trades at $1.5 (market cap $138.04M). The key difference: 10X Genomics Inc is far larger — about 55.1× Veritone Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| TXG | VERI | |
|---|---|---|
Market Cap | $7.61B | $138.04M |
Sector | Health | Technology |
52-Week High | $58.57 | $8.39 |
52-Week Low | $11.34 | $1.00 |
Enterprise Value | $7.14B | $170.07M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
